Skip to main content

Table 6 The first 25 query results for query #12

From: The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside

drug name disease2 _name
(s)-rolipram Schizophrenia
(s)-rolipram Autistic Disorder
(s)-rolipram Bipolar Disorder
(s)-rolipram Depression
ACE INHIBITORS, PLAIN Angioneurotic Edema
ACE INHIBITORS, PLAIN Hypertension
ACE INHIBITORS, PLAIN Hypertrophy, Left Ventricular
ACE INHIBITORS, PLAIN Coronary Disease
ACE INHIBITORS, PLAIN Alzheimer Disease
ACE INHIBITORS, PLAIN nondiabetic proteinuric nephropathy
ACE INHIBITORS, PLAIN Alcoholism
ACE INHIBITORS, PLAIN Abnormalities
ACE INHIBITORS, PLAIN Fetal Death
ACE INHIBITORS, PLAIN Cardiovascular Abnormalities
ACE INHIBITORS, PLAIN Cardiovascular Diseases
ACE INHIBITORS, PLAIN Cough
ACE INHIBITORS, PLAIN Heart Failure
ACE INHIBITORS, PLAIN Kidney Diseases
ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS Cardiovascular Diseases
ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS Hypertension
ANTIPSYCHOTICS Schizophrenia
BETA BLOCKING AGENTS Abnormalities
BETA BLOCKING AGENTS Fetal Death
BETA BLOCKING AGENTS Cardiovascular Abnormalities
atenolol glomerulosclerosis
... ...
  1. A selection of existing marketed drugs in TMKB that might potentially be candidates for AD because they are known to modulate genes that are implicated in the disease.